FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES Stock

Certificat

DE000MG394E8

Market Closed - Börse Stuttgart 15:49:04 2024-06-14 EDT
3.26 EUR +16.01% Intraday chart for FAKTOR-OPTIONSSCHEIN - COOPER COMPANIES
Current month+8.31%
1 month-46.47%
Date Price Change
24-06-14 3.26 +16.01%
24-06-13 2.81 +3.69%
24-06-12 2.71 -12.58%
24-06-11 3.1 +10.71%
24-06-10 2.8 -2.78%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:49 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Morgan Stanley
WKN MG394E
ISINDE000MG394E8
Date issued 2024-04-29
Strike 103.6 $
Maturity Unlimited
Parity 3.05 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.15
Lowest since issue 2.52
Spread 0.05
Spread %1.55%

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
93.47 USD
Average target price
108.2 USD
Spread / Average Target
+15.71%
Consensus